Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children

Thomas G. Burns, Gregory P. Lee, Megan L. McCormick, Ashley N. Pettoni, J. Robert Flamini, Morris Cohen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The intracarotid amobarbital procedure (IAP) is routinely conducted as part of the presurgical evaluation of pediatric patients with epilepsy. The aim of the present study was to investigate the possibility that anesthetization failures are the result of interactions of carbonic anhydrase-inhibiting (CAI) medications with sodium amobarbital. An archival review of 81 cases conducted between 1999 and 2008 was performed across two pediatric epilepsy centers. χ2 analysis was used to assess whether CAI medications interfered with the outcome of these procedures. Of 81 patients, 85.2% had conclusive findings. All of the remaining 14.8% with anesthetization failures were taking CAI medications at the time of the procedure. However, 53.8% of patients taking CAI medications had conclusive results. This suggests that these medications may interact with sodium amobarbital, raising the possibility of anesthetization failures in children prescribed CAI medications.

Original languageEnglish (US)
Pages (from-to)240-244
Number of pages5
JournalEpilepsy and Behavior
Volume15
Issue number2
DOIs
StatePublished - Jun 1 2009

Fingerprint

Amobarbital
Carbonic Anhydrases
Epilepsy
Pediatrics

Keywords

  • Antiepileptic medications
  • Epilepsy
  • Intracarotid amobarbital procedure
  • Neuropsychology
  • Pediatrics
  • Wada procedure

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cite this

Burns, T. G., Lee, G. P., McCormick, M. L., Pettoni, A. N., Flamini, J. R., & Cohen, M. (2009). Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children. Epilepsy and Behavior, 15(2), 240-244. https://doi.org/10.1016/j.yebeh.2009.01.006

Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children. / Burns, Thomas G.; Lee, Gregory P.; McCormick, Megan L.; Pettoni, Ashley N.; Flamini, J. Robert; Cohen, Morris.

In: Epilepsy and Behavior, Vol. 15, No. 2, 01.06.2009, p. 240-244.

Research output: Contribution to journalArticle

Burns, TG, Lee, GP, McCormick, ML, Pettoni, AN, Flamini, JR & Cohen, M 2009, 'Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children', Epilepsy and Behavior, vol. 15, no. 2, pp. 240-244. https://doi.org/10.1016/j.yebeh.2009.01.006
Burns, Thomas G. ; Lee, Gregory P. ; McCormick, Megan L. ; Pettoni, Ashley N. ; Flamini, J. Robert ; Cohen, Morris. / Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children. In: Epilepsy and Behavior. 2009 ; Vol. 15, No. 2. pp. 240-244.
@article{edfaaaad7e1a4f7baf0254960e073c0e,
title = "Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children",
abstract = "The intracarotid amobarbital procedure (IAP) is routinely conducted as part of the presurgical evaluation of pediatric patients with epilepsy. The aim of the present study was to investigate the possibility that anesthetization failures are the result of interactions of carbonic anhydrase-inhibiting (CAI) medications with sodium amobarbital. An archival review of 81 cases conducted between 1999 and 2008 was performed across two pediatric epilepsy centers. χ2 analysis was used to assess whether CAI medications interfered with the outcome of these procedures. Of 81 patients, 85.2{\%} had conclusive findings. All of the remaining 14.8{\%} with anesthetization failures were taking CAI medications at the time of the procedure. However, 53.8{\%} of patients taking CAI medications had conclusive results. This suggests that these medications may interact with sodium amobarbital, raising the possibility of anesthetization failures in children prescribed CAI medications.",
keywords = "Antiepileptic medications, Epilepsy, Intracarotid amobarbital procedure, Neuropsychology, Pediatrics, Wada procedure",
author = "Burns, {Thomas G.} and Lee, {Gregory P.} and McCormick, {Megan L.} and Pettoni, {Ashley N.} and Flamini, {J. Robert} and Morris Cohen",
year = "2009",
month = "6",
day = "1",
doi = "10.1016/j.yebeh.2009.01.006",
language = "English (US)",
volume = "15",
pages = "240--244",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Carbonic anhydrase-inhibiting medications and the intracarotid amobarbital procedure in children

AU - Burns, Thomas G.

AU - Lee, Gregory P.

AU - McCormick, Megan L.

AU - Pettoni, Ashley N.

AU - Flamini, J. Robert

AU - Cohen, Morris

PY - 2009/6/1

Y1 - 2009/6/1

N2 - The intracarotid amobarbital procedure (IAP) is routinely conducted as part of the presurgical evaluation of pediatric patients with epilepsy. The aim of the present study was to investigate the possibility that anesthetization failures are the result of interactions of carbonic anhydrase-inhibiting (CAI) medications with sodium amobarbital. An archival review of 81 cases conducted between 1999 and 2008 was performed across two pediatric epilepsy centers. χ2 analysis was used to assess whether CAI medications interfered with the outcome of these procedures. Of 81 patients, 85.2% had conclusive findings. All of the remaining 14.8% with anesthetization failures were taking CAI medications at the time of the procedure. However, 53.8% of patients taking CAI medications had conclusive results. This suggests that these medications may interact with sodium amobarbital, raising the possibility of anesthetization failures in children prescribed CAI medications.

AB - The intracarotid amobarbital procedure (IAP) is routinely conducted as part of the presurgical evaluation of pediatric patients with epilepsy. The aim of the present study was to investigate the possibility that anesthetization failures are the result of interactions of carbonic anhydrase-inhibiting (CAI) medications with sodium amobarbital. An archival review of 81 cases conducted between 1999 and 2008 was performed across two pediatric epilepsy centers. χ2 analysis was used to assess whether CAI medications interfered with the outcome of these procedures. Of 81 patients, 85.2% had conclusive findings. All of the remaining 14.8% with anesthetization failures were taking CAI medications at the time of the procedure. However, 53.8% of patients taking CAI medications had conclusive results. This suggests that these medications may interact with sodium amobarbital, raising the possibility of anesthetization failures in children prescribed CAI medications.

KW - Antiepileptic medications

KW - Epilepsy

KW - Intracarotid amobarbital procedure

KW - Neuropsychology

KW - Pediatrics

KW - Wada procedure

UR - http://www.scopus.com/inward/record.url?scp=67349108778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349108778&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2009.01.006

DO - 10.1016/j.yebeh.2009.01.006

M3 - Article

C2 - 19208439

AN - SCOPUS:67349108778

VL - 15

SP - 240

EP - 244

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 2

ER -